{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:35:47Z","timestamp":1784144147044,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.cbi.2006.10.001","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T07:37:56Z","timestamp":1160552276000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Study of feasibility of the treatment with procainamide hydrochloride and cisplatin in pregnant mice"],"prefix":"10.1016","volume":"164","author":[{"given":"Emanuela","family":"Ognio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Chiavarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Peterka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Mariggi\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2006.10.001_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.1994.1347","article-title":"Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomised trials","volume":"55","author":"Thigpen","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0748-7983(97)90966-5","article-title":"Current concept about testicular cancer","volume":"23","author":"Van Basten","year":"1997","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/1097-0142(20010815)92:4<814::AID-CNCR1387>3.0.CO;2-8","article-title":"Ifosfamide, cisplatin, and 13-cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I\u2013II study","volume":"92","author":"Recchia","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2006.10.001_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0162-0134(99)00135-X","article-title":"Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches","volume":"77","author":"Screnci","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2006.10.001_bib5","first-page":"170","article-title":"History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity","volume":"1","author":"Sweeney","year":"2001","journal-title":"Semin. Urol. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF01960376","article-title":"Embryotoxicity and teratogenicity of cis-diamminedichloroplatinum","volume":"35","author":"Lazar","year":"1979","journal-title":"Experientia"},{"key":"10.1016\/j.cbi.2006.10.001_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0041-008X(83)90305-8","article-title":"Embryotoxicity of cisplatin in rats and mice","volume":"69","author":"Keller","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2006.10.001_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0041-008X(85)90104-8","article-title":"An analysis of factors responsible for resorption of embryos in cisplatin-treated rats","volume":"80","author":"Bajt","year":"1985","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2006.10.001_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0300-483X(85)90143-X","article-title":"Lack of severe malformations versus occurrence of marked embryotoxic effects after treatment of pregnant mice with cis-platinum","volume":"34","author":"K\u00f6pf-Maier","year":"1985","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2006.10.001_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000055371","article-title":"Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy","volume":"61","author":"J\u00e4nne","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.cbi.2006.10.001_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1529::AID-CNCR15>3.0.CO;2-6","article-title":"Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy","volume":"82","author":"Tewari","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2006.10.001_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000012017","article-title":"Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma","volume":"57","author":"Bohm","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.cbi.2006.10.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(90)90257-U","article-title":"l-Methionine antagonism of cis-platinum nephrotoxicity","volume":"103","author":"Basinger","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2006.10.001_bib14","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/carcin\/14.12.2595","article-title":"Para-Aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity","volume":"12","author":"Esposito","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2006.10.001_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2310\/7070.2003.11264","article-title":"Assessment of the protective effects of amifostine against cisplatin-induced toxicity","volume":"32","author":"Hussain","year":"2003","journal-title":"J. Otolaryngol."},{"key":"10.1016\/j.cbi.2006.10.001_bib16","first-page":"522","article-title":"Amifostine in reducing cisplatin toxicity","volume":"25","author":"Markman","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00001622-199507000-00003","article-title":"Strategies to prevent nephrotoxicity of anticancer drugs","volume":"7","author":"Skinner","year":"1995","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/taap.1996.0233","article-title":"Effect of antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II)","volume":"140","author":"Esposito","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2006.10.001_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(24)39304-8","article-title":"Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?","volume":"293","author":"Viale","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2006.10.001_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0014-2999(02)01537-6","article-title":"Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats","volume":"442","author":"Zicca","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.cbi.2006.10.001_bib21","first-page":"180","article-title":"Potentiation of cisplatin (DDP)-induced apoptosis by procainamide hydrochloride (PdHCl) in murine P388 leukemia cells in vitro","volume":"4","author":"Ottone","year":"2005","journal-title":"Tumori"},{"key":"10.1016\/j.cbi.2006.10.001_bib22","series-title":"Teratology: Principles and Techniques","first-page":"262","article-title":"Methods for administering agents and detecting malformations in experimental animals","author":"Wilson","year":"1965"},{"key":"10.1016\/j.cbi.2006.10.001_bib23","first-page":"61","article-title":"Refinements in rapid clearing technic in the KOH-Alizarin Red S method for foetal bone","volume":"39","author":"Staples","year":"1964","journal-title":"Stain. Technol."},{"key":"10.1016\/j.cbi.2006.10.001_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9926(199704)55:4<249::AID-TERA5>3.0.CO;2-W","article-title":"Terminology of developmental abnormalities in common laboratory mammals (Version 1)","volume":"55","author":"Wise","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.cbi.2006.10.001_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/tera.1420200208","article-title":"The extent of fetal ossification as an index of delayed development in teratogenic studies on the rat","volume":"20","author":"Aliverti","year":"1979","journal-title":"Teratology"},{"key":"10.1016\/j.cbi.2006.10.001_bib26","first-page":"1509","article-title":"Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia","volume":"23","author":"Vannozzi","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2006.10.001_bib27","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19880601)61:11<2192::AID-CNCR2820611110>3.0.CO;2-A","article-title":"Cisplatin neuropathy risk factors, prognosis and protection by WR-2721","volume":"61","author":"Mollman","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2006.10.001_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<866::AID-IJC34>3.0.CO;2-9","article-title":"Platinum organ toxicity and possible prevention in patients with testicular cancer","volume":"83","author":"Hartmann","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2006.10.001_bib29","first-page":"460","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Sem. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0277-5379(83)90118-9","article-title":"Stage of pregnancy-dependent transplacental passage of 195Pt after cis-platinum treatment","volume":"19","author":"K\u00f6pf-Maier","year":"1983","journal-title":"Eur. Cancer Clin. Oncol."},{"key":"10.1016\/j.cbi.2006.10.001_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/tera.1420280106","article-title":"Potentiating effects of caffeine on teratogenicity of alkylating agents in mice","volume":"28","author":"Fujii","year":"1983","journal-title":"Teratology"},{"key":"10.1016\/j.cbi.2006.10.001_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-1110(86)90020-5","article-title":"Toxicological review of busulfan (Myleran)","volume":"168","author":"Bishop","year":"1986","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2006.10.001_bib33","series-title":"Proceedings of the Fourth International Platinum Symposium","first-page":"158","article-title":"Embryotoxicity of cisplatin in rats and mice: possible factors responsible","author":"Aggarwal","year":"1983"},{"issue":"Suppl. 4","key":"10.1016\/j.cbi.2006.10.001_bib34","first-page":"135","article-title":"Modulation of the therapeutic efficacy of cisplatin in rats using procainamide","volume":"81","author":"Esposito","year":"1995","journal-title":"Tumori"},{"key":"10.1016\/j.cbi.2006.10.001_bib35","first-page":"2285","article-title":"Synthesis and antitumour activity of a new cis-diammineplatinum(II) complex containing procaine hydrochloride","volume":"12","author":"Cafaggi","year":"1992","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2006.10.001_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00002018-199920010-00008","article-title":"Treatment of cardiac arrhythmias during pregnancy: safety considerations","volume":"20","author":"Joglar","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.cbi.2006.10.001_bib37","first-page":"623","article-title":"Management of cardiac arrhytmias during pregnancy","volume":"33","author":"Rotmensch","year":"1987","journal-title":"Current Concepts Drugs"},{"key":"10.1016\/j.cbi.2006.10.001_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-5273(02)00601-0","article-title":"Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations","volume":"88","author":"Gowda","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cbi.2006.10.001_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/dmd.31.2.153","article-title":"The presence of xenobiotic transporters in rat placenta","volume":"31","author":"Leazer","year":"2003","journal-title":"Drug Met. Disp."},{"key":"10.1016\/j.cbi.2006.10.001_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(24)39087-1","article-title":"Placental transporters relevant to drug distribution across the maternal\u2013fetal interface","volume":"294","author":"Ganapathy","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2006.10.001_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01037945","article-title":"Cimetidine\u2013procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs","volume":"25","author":"Somoyi","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2006.10.001_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00204-004-0576-x","article-title":"Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-aminobenzoate, N4]-chloride platinum (II) monohydrochloride monohydrate","volume":"78","author":"Ognio","year":"2004","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2006.10.001_bib43","first-page":"1859","article-title":"Pharmacokinetic analysis of intra-peritoneal administration of cisplatin","volume":"24","author":"Terashima","year":"1997","journal-title":"Gan Kagaku Ryoko"},{"key":"10.1016\/j.cbi.2006.10.001_bib44","first-page":"235","article-title":"Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route","volume":"67","author":"Casper","year":"1983","journal-title":"Cancer Treat. Rep."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279706002870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279706002870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:12:46Z","timestamp":1757855566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279706002870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0009279706002870"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2006.10.001","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of feasibility of the treatment with procainamide hydrochloride and cisplatin in pregnant mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2006.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}